Some studies have shown a correlation between ERα expression and improved outcomes in epithelial ovarian carcinoma patients [37, 38], whereas other studies show increased ERα expression decreases the overall survival of ovarian cancer patients [39, 40]. Here, ESR1 is linked to ovarian carcinoma.